Back
ARS Pharmaceuticals, Inc. Stock Predictions
$10K Investment in Nvidia Could've Made $2.5M
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
35
SPRY
ARS Pharmaceuticals, Inc.
Last Price:
$10.03
Seasonality Move:
-5.05%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Phase of AI Is Not About Chat
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.comARS Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, ARS Pharmaceuticals, Inc. has on average historically risen by 9% based on the past 5 years of stock performance.
-
ARS Pharmaceuticals, Inc. has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is ARS Pharmaceuticals, Inc. Stock Undervalued?The current ARS Pharmaceuticals, Inc. [SPRY] share price is $10.03. The Score for SPRY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
SPRY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will ARS Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, ARS Pharmaceuticals, Inc. has on average historically risen by 9% based on the past 5 years of stock performance.
ARS Pharmaceuticals, Inc. Stock Rating
Sell
35
ARS Pharmaceuticals, Inc. (SPRY)
is a Sell
Is ARS Pharmaceuticals, Inc. overpriced?
-
ARS Pharmaceuticals, Inc. has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
ARS Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ars-pharma.com
52-Week Data
52-Week High:
18.90
52-Week Low:
6.66
Prediction Charts
Market Cap:
991.5M
Price in USD:
10.03
Volume:
1.2M
Beta:
0.80
Technical Analysis
SMA50:
10.56
SMA100:
9.98
SMA200:
12.49
52-Wk Change:
-21.64%
Stock Predictions
-
Is ARS Pharmaceuticals, Inc. stock public?Yes, ARS Pharmaceuticals, Inc. is a publicly traded company.
-
What is the ARS Pharmaceuticals, Inc. stock quote today?The ARS Pharmaceuticals, Inc. stock price is 10.03 USD today.
-
How to buy ARS Pharmaceuticals, Inc. stock online?You can buy ARS Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-20 | 10.34 | 10.45 | 10.74 | 10.22 |
| Jan-21 | 10.25 | 10.44 | 10.50 | 10.02 |
| Jan-22 | 10.46 | 10.57 | 10.88 | 10.40 |
| Jan-23 | 10.50 | 10.21 | 10.88 | 10.21 |
| Jan-26 | 10.18 | 10.48 | 10.68 | 10.01 |
| Jan-27 | 10.55 | 10.54 | 10.79 | 10.23 |
| Jan-28 | 10.50 | 10.06 | 10.50 | 10.00 |
| Jan-29 | 10.09 | 10.22 | 10.37 | 9.85 |
| Jan-30 | 10.24 | 9.99 | 10.27 | 9.84 |
| Feb-2 | 9.95 | 10.30 | 10.44 | 9.61 |
| Feb-3 | 10.28 | 10.15 | 10.74 | 10.10 |
| Feb-4 | 10.29 | 10.14 | 10.38 | 9.97 |
| Feb-5 | 10.12 | 9.67 | 10.28 | 9.60 |
| Feb-6 | 9.87 | 10.03 | 10.05 | 9.70 |
ARS Pharmaceuticals, Inc. Earnings
ARS Pharmaceuticals, Inc. Earnings Report: Per Share ARS Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
ARS Pharmaceuticals, Inc. Forecast Revenue Growth
ARS Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for ARS Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and an increase next year of $0.89 per share.
* ARS Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.